Literature DB >> 17548055

TLR2 has a detrimental role in mouse transient focal cerebral ischemia.

Gina Ziegler1, Denise Harhausen, Claudia Schepers, Olaf Hoffmann, Christina Röhr, Vincent Prinz, Janett König, Hans Lehrach, Wilfried Nietfeld, George Trendelenburg.   

Abstract

A significant up-regulation of Toll-like-receptor (TLR) mRNAs between 3 and 48 h reperfusion time after induction of transient focal cerebral ischemia for 1h was revealed by applying global gene expression profiling in postischemic mouse brains. Compared to TLR4 and TLR9, TLR2 proved to be the most significantly up-regulated TLR in the ipsilateral brain hemisphere. TLR2-protein was found to be expressed mainly in microglia in the postischemic brain tissue, but also in selected endothelial cells, neurons, and astrocytes. Additionally, TLR2-related genes with pro-inflammatory and pro-apoptotic capabilities were induced. Therefore we hypothesized that TLR2-signaling could exacerbate the primary brain damage after ischemia. Two days after induction of transient focal cerebral ischemia (1h), we found a significant decrease of the infarct volume in TLR2 deficient mice compared to wild type mice (75+/-5 vs. 42+/-7 mm(3)). We conclude that TLR2 up-regulation and TLR2-signaling are important events in focal cerebral ischemia and contribute to the deterioration of ischemic damage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548055     DOI: 10.1016/j.bbrc.2007.05.157

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  112 in total

1.  Microglial Toll-like receptor 2 contributes to kainic acid-induced glial activation and hippocampal neuronal cell death.

Authors:  Jinpyo Hong; Ik-Hyun Cho; Kyung Il Kwak; Eun Cheng Suh; Jinsoo Seo; Hyun Jung Min; Se-Young Choi; Chong-Hyun Kim; Seung Hwa Park; Eun-Kyeong Jo; Soojin Lee; Kyung Eun Lee; Sung Joong Lee
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

Review 2.  Regulation of microglial activation in stroke.

Authors:  Shou-Cai Zhao; Ling-Song Ma; Zhao-Hu Chu; Heng Xu; Wen-Qian Wu; Fudong Liu
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

3.  Combination therapy with VELCADE and tissue plasminogen activator is neuroprotective in aged rats after stroke and targets microRNA-146a and the toll-like receptor signaling pathway.

Authors:  Li Zhang; Michael Chopp; Xianshuang Liu; Hua Teng; Tao Tang; Haifa Kassis; Zheng Gang Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-21       Impact factor: 8.311

Review 4.  Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS?

Authors:  Catherine E Downes; Peter J Crack
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 5.  The neurovascular unit and combination treatment strategies for stroke.

Authors:  Li Zhang; Zheng Gang Zhang; Michael Chopp
Journal:  Trends Pharmacol Sci       Date:  2012-05-16       Impact factor: 14.819

Review 6.  Inflammatory responses in brain ischemia.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 7.  MicroRNAs regulate the chaperone network in cerebral ischemia.

Authors:  Yi-Bing Ouyang; Rona G Giffard
Journal:  Transl Stroke Res       Date:  2013-08-17       Impact factor: 6.829

8.  DIDS protects against neuronal injury by blocking Toll-like receptor 2 activated-mechanisms.

Authors:  Hang Yao; Hady Felfly; Juan Wang; Dan Zhou; Gabriel G Haddad
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

Review 9.  Linking oxidative stress to inflammation: Toll-like receptors.

Authors:  Roop Gill; Allan Tsung; Timothy Billiar
Journal:  Free Radic Biol Med       Date:  2010-01-18       Impact factor: 7.376

10.  Ginkgolides and bilobalide protect BV2 microglia cells against OGD/reoxygenation injury by inhibiting TLR2/4 signaling pathways.

Authors:  Jian-Ming Zhou; Sha-Sha Gu; Wang Hong Mei; Jun Zhou; Zhen Zhong Wang; Wei Xiao
Journal:  Cell Stress Chaperones       Date:  2016-08-25       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.